Got something to say about drugs? We’re always on the look out for unique angles and informed, nuanced insights into drug policy—and we pay for content. Politics, tech, medicine, case studies, opinion, policy, interviews get your drug story pitches to us.
ABOUT THE COMPANY
Volteface is an independent research and advocacy organisation that seeks to reduce the harm drugs pose to individuals and society, through evidence-based policy reform. It cultivates fresh thinking and new ideas through its policy reports and online magazine.
We’re always open to pitches. We commission on a rolling basis. No deadline but obviously the sooner the better as we have a set monthly budget.
WHAT TO INCLUDE IN SUBMISSION
COMPENSATION
CONTACT
For more information, visit their website.
Email all questions and submissions to Katya Kowalski, Head of Operations at Volteface, at: katya@volteface.me
John Hayes, a stalwart of the Financial Times’ sub-editing desk, has died at the age…
Fortune is hiring a Global News Director to oversee breaking news coverage across Europe, the…
David Szymanski, a business journalist in the Tampa Bay area dating back to the 1980s,…
Charlotte Tobitt of Press Gazette interviewed Wall Street Journal editor in chief Emma Tucker on how it can…
The New York Times, Reuters, Bloomberg and Bloomberg Businessweek received Deadline Club awards for business…
The Wall Street Journal seeks an experienced journalist to become Business, Finance & Economics Editor…